Patents Assigned to NANJING BAIXINYU PHARMACEUTICAL CO. LTD.
  • EDARAVONE PHARMACEUTICAL COMPOSITION
    Publication number: 20210244657
    Abstract: Disclosed in the present invention are an edaravone pharmaceutical composition and an application thereof as a sublingual preparation, the pharmaceutical composition containing edaravone or a salt thereof and mannitol. A sublingual administration preparation can avoid the first-pass effect of the liver, and samples feature good stability, convenience of transport and of use, among other advantages.
    Type: Application
    Filed: December 27, 2018
    Publication date: August 12, 2021
    Applicants: BEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY, NANJING BAIXINYU PHARMACEUTICAL CO. LTD.
    Inventors: Yilong WANG, Yongjun WANG, Xingquan ZHAO, Anyuan ZHANG